Want to watch a higher priced stock go through the roof?
VICL might double or more today.
-------------------- Making it a little at a time....Now is the time to determine if you are a man or a mouse. Posts: 1543 | From: Ogilvie, MN, US | Registered: Apr 2004
| IP: Logged |
posted
iVoice Announces Agreement with Lamson Holding LLC, for Sale of Selected Patents
May 04, 2006 06:16:01 (ET)
MATAWAN, N.J., May 04, 2006 (BUSINESS WIRE) -- iVoice, Inc. (IVOI, Trade), announced today that it had authorized an agreement with Lamson Holdings LLC, for the sale of selected patents. The transaction, which is subject to due diligence and the usual and customary conditions, is expected to close in May 2006.
On March 21, 2006, the Company entered into a Patent Purchase Agreement with Lamson Holdings LLC, for the sale of certain United States Letters Patents and/or applications for United States Letters Patents and/or foreign patents and applications. The patents and/or patent applications being transferred in this purchase agreement relate to various Voice Activated/Voice Responsive systems developed by iVoice, including item locators for retail stores utilizing various unique identifying, data gathering and organizing, as well as user feedback techniques.
A portion of the proceeds are to be disbursed to GlynnTech, Inc. which served as iVoice's licensing agent, to assist iVoice, Inc. in unlocking the potential value of the pending and issued patents. Also, some of the patents were co-invented by the President of GlynnTech, Inc., Ken Glynn.
About iVoice, Inc.
iVoice has determined that the best way to create shareholder value, separate and apart from the operating performance of iVoice, is to implement new business opportunities by distributing shares of spin-offs to the Company's shareholders. The common stock distributions are part of a broader strategy relating to the transition of iVoice into a company focused on the development and licensing of proprietary technologies. We also continue to search for potential merger candidates with or without compatible technology and products, which management feels may offer long term growth prospects to increase shareholder value. For more information, contact CEO Jerry Mahoney at (732) 441 7700 or by e-mail at jerrym*ivoice.com.
Certain information included in this press release, may contain forward-looking statements about our current and expected performance trends, growth plans, business goals and other matters. These statements may be contained in our filings with the Securities and Exchange Commission, in our press releases, in other written communications, and in oral statements made by or with the approval of one of our authorized officers. Information set forth in this press release contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995 (the "Act") provides certain "safe harbor" provisions for forward-looking statements. The reader is cautioned that such forward-looking statements are based on information available at the time and/or management's good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Factors that could cause or contribute to such differences include, but are not limited to those risk factors that are set forth in the section entitled "Forward Looking Statements - Cautionary Factors" in the Company's Form 10-KSB for fiscal year ended December 31, 2004 and other filings with the Securities and Exchange Commission from time to time. Forward-looking statements speak only as of the date the statement was made. We assume no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. Forward-looking statements are typically identified by the use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "project," "should," "will," and similar words, although some forward-looking statements are expressed differently. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.
posted
(BSNS WIRE) iVoice Announces Thomas Pharmaceuticals Acid + All(TM) To Grace W lgreens' Store Shelves This June; Thomas Pharmaceutic iVoice Announces Thomas Pharmaceuticals Acid + All(TM) To Grace Walgreens' Store Shelves This June; Thomas Pharmaceuticals is a Wholly Owned Subsidiary of iVoice Inc.
Business Editors / Retail Writers
MATAWAN, N.J.--(BUSINESS WIRE)--May 16, 2006--
Acid + All(TM) is Bringing Substance with Style to Walgreens Stores Nationwide
Thomas Pharmaceuticals, a wholly owned subsidiary of iVoice, Inc. (OTCBB: IVOI), announced today that it has shipped its first order for Acid + All(TM) to Walgreens drugstores, which has over 5200 drugstores nationwide. A sleekly packaged, high-end antacid tablet, Acid + All(TM) is giving the over-the-counter category a makeover by refusing to forego fashion in favor of function. Consumers will now be able to find Acid + All(TM)'s chic blue and white tin at their local Walgreens drugstore in early June. "We are excited about shipping our first national order of Acid + All(TM) to Walgreens, making substance with style available nationwide," Tom Thomas, president and founder of Thomas Pharmaceuticals, said. "We value and respect the trust we have earned with Walgreens and look forward to a long term relationship between Thomas Pharmaceuticals and them." Acid + All(TM), the calcium enriched, spearmint-flavored, sugar free tablets that soothe heartburn, acid indigestion and gas is available at independent pharmacies, major drug chains and online retailers or by calling toll-free at 1-888-922-1959. Acid + All(TM) will be available in a sleek, 32-count pillbox and will retail for approximately $3.89. Thomas Pharmaceutical plans to introduce Acid + All(TM) line extensions later this year along with other new over-the-counter products. For more information about Acid + All(TM) go to www.acidall.com.
About Thomas Pharmaceuticals Ltd:
Thomas Pharmaceuticals Ltd., based in New York, NY, develops and markets over the counter non-prescription healthcare products. The company focuses on high-end, branded consumables. Its first product, Acid + All(TM), is a calcium-enriched, sugar free, anti-gas antacid.
About iVoice, Inc:
iVoice has determined that the best way to create shareholder value, separate and apart from the operating performance of iVoice, is to implement new business opportunities by distributing shares of spin-offs to the company's shareholders. The common stock distributions are part of a broader strategy relating to the transition of iVoice into a company focused on the development and licensing of proprietary technologies. We also continue to search for potential merger candidates with or without compatible technology and products, which management feels may make financing more appealing to potential investors.
Certain information included in this press release, may contain forward-looking statements about our current and expected performance trends, growth plans, business goals and other matters. These statements may be contained in our filings with the Securities and Exchange Commission, in our press releases, in other written communications, and in oral statements made by or with the approval of one of our authorized officers. Information set forth in this press release contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995 (the "Act") provides certain "safe harbor" provisions for forward-looking statements. The reader is cautioned that such forward-looking statements are based on information available at the time and/or management's good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Forward-looking statements speak only as of the date the statement was made. We assume no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. Forward-looking statements are typically identified by the use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "project," "should," "will," and similar words, although some forward-looking statements are expressed differently. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.
KEYWORD: NORTH AMERICA NEW JERSEY UNITED STATES INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL RETAIL FOOD/BEVERAGE SPECIALTY PRODUCT/S RVICE SOURCE: iVoice, Inc.
CONTACT INFORMATION: iVoice, Inc. Dolores Serafin, 732-441-7700 Just say "Investor Relations" investors*ivoice.com http://www.ivoice.com
*** end of story ***
Posts: 194 | From: N. Ireland | Registered: Nov 2004
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
